A detailed history of Fiduciary Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Fiduciary Trust CO holds 299,605 shares of ABBV stock, worth $53.9 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
299,605
Previous 299,935 0.11%
Holding current value
$53.9 Million
Previous $51.4 Million 15.01%
% of portfolio
0.85%
Previous 0.79%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $54,067 - $65,778
-330 Reduced 0.11%
299,605 $59.2 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $244,722 - $285,781
-1,581 Reduced 0.52%
299,935 $51.4 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $189,386 - $215,788
1,185 Added 0.39%
301,516 $54.9 Million
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $1.16 Million - $1.31 Million
-8,454 Reduced 2.74%
300,331 $46.5 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $568,291 - $657,881
-4,254 Reduced 1.36%
308,785 $46 Million
Q2 2023

Aug 01, 2023

SELL
$132.51 - $164.9 $267,140 - $332,438
-2,016 Reduced 0.64%
313,039 $42.2 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $590,298 - $679,816
-4,082 Reduced 1.28%
315,055 $50.2 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $233,882 - $280,486
-1,691 Reduced 0.53%
319,137 $51.6 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $6,173 - $7,080
-46 Reduced 0.01%
320,828 $43.1 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $1.44 Million - $1.83 Million
-10,435 Reduced 3.15%
320,874 $49.1 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $2.41 Million - $2.99 Million
-18,289 Reduced 5.23%
331,309 $53.7 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $1.25 Million - $1.58 Million
-11,634 Reduced 3.22%
349,598 $47.3 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $72,564 - $82,371
-682 Reduced 0.19%
361,232 $39 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $1.92 Million - $2.14 Million
18,241 Added 5.31%
361,914 $40.8 Million
Q1 2021

May 19, 2021

BUY
$102.3 - $112.62 $753,644 - $829,671
7,367 Added 2.19%
343,673 $37.2 Million
Q4 2020

Jan 26, 2021

BUY
$80.49 - $108.67 $817,617 - $1.1 Million
10,158 Added 3.11%
336,306 $36 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $877,312 - $1.03 Million
10,212 Added 3.23%
326,148 $28.6 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $867,600 - $1.16 Million
11,825 Added 3.89%
315,936 $31 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $330,756 - $501,467
5,128 Added 1.72%
304,111 $23.2 Million
Q4 2019

Feb 04, 2020

BUY
$72.13 - $90.25 $392,747 - $491,411
5,445 Added 1.85%
298,983 $26.5 Million
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $156,568 - $188,239
2,486 Added 0.85%
293,538 $22.2 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $381,454 - $487,587
5,806 Added 2.04%
291,052 $21.2 Million
Q1 2019

May 07, 2019

SELL
$77.14 - $90.79 $748,720 - $881,207
-9,706 Reduced 3.29%
285,246 $23 Million
Q4 2018

Jan 29, 2019

SELL
$77.85 - $96.01 $414,629 - $511,349
-5,326 Reduced 1.77%
294,952 $27.2 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $835,487 - $928,799
-9,397 Reduced 3.03%
300,278 $28.4 Million
Q2 2018

Aug 03, 2018

SELL
$89.78 - $106.23 $850,485 - $1.01 Million
-9,473 Reduced 2.97%
309,675 $28.7 Million
Q1 2018

May 08, 2018

SELL
$92.01 - $123.21 $448,732 - $600,895
-4,877 Reduced 1.51%
319,148 $30.2 Million
Q4 2017

Jan 29, 2018

SELL
$89.56 - $98.21 $118,487 - $129,931
-1,323 Reduced 0.41%
324,025 $31.3 Million
Q3 2017

Nov 02, 2017

BUY
$69.85 - $89.22 $22.7 Million - $29 Million
325,348
325,348 $28.9 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fiduciary Trust CO Portfolio

Follow Fiduciary Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.